BI 764532
Boehringer Ingelheim
['sclc']
3: the ongoing phase i trial (nct04429087) tests bi 764532 in adults with locally advanced/metastatic dll3+ sclc, nec, or large cell nec (lcnec). the drug is administered intravenously using three different regimens. #clinicaltrials #asco23 
🫁Pneumo-Onco🩺 Chef de Pôle de Méd à Orientation Onco 🏥 @CHToulonLaSeyne 🔬Conseil Scientifique @IFCTLung / Pdte du 3C VarOuest 👉🏼#HopitalPublic #LungCancer